Open Nav

Please submit your session questions in advance at http://bit.ly/BIOCEO19question

Sanjay Shukla

President and CEO

aTyr Pharma, Inc.

Sanjay Shukla, MD, MS has served as our President and CEO and as a board member since November 2017. Dr. Shukla served as our Chief Medical Officer from March 2016 to November 2017. From April 2015 to March 2016, Dr. Shukla worked in an advisory capacity for a number of companies, including as a consultant to aTyr from January 2016 to March 2016. Prior to that, from October 2012 to April 2015, Dr. Shukla served as Vice President and Global Head of Integrated Medical Services for Novartis where he led global medical affairs operations with oversight for all pharma general medicines therapies, both inline and in development. Dr. Shukla served as CEO of RXMD, a clinical development consultancy that assisted in advancing proof of concept for early stage drug candidates, from April 2009 to September 2012. Prior to that, Dr. Shukla served in a variety of clinical development, data analytics and drug safety roles at Vifor Pharma, a biopharmaceutical company, and Aspreva Pharmaceuticals.

This speaker's sessions:

Back